MGX
Metagenomi, Inc. Common Stock
NASDAQ · USHealthcareBiotechnology
$1.22-1.61%
Price as of Jul 20, 2026
MGX profitability
Metagenomi, Inc. Common Stock profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- -16.4%
- EBITDA margin
- -361.8%
- EBIT margin
- -415.5%
- Net margin
- -384.6%
- Free cash flow margin
- -392.0%
Returns
- Return on equity
- -62.3%
- Return on assets
- -43.6%
- Return on invested capital
- -52.4%
- Asset turnover
- 0.11x
Cash efficiency
- Cash from operations
- -$87.2M
- Cash per share
- $3.72
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.